Healthcare provider profile · identity verified

Joe D Burghard, MD

Family Practice · LIBERTY TOWNSHIP, OH · NPI 1073514568

Profile state: partd only Open Payments: 2025 Medicare Part D: 2024 Last identity check: 2026-08-10 Page data build: 2026-08-12

Verified facts

What the public records show

We did not find matching Open Payments records for this doctor in 2025.

These records do not establish that a payment influenced prescribing or medical care.

Payment overview · 2025

General Payments

We did not find matching Open Payments records for this doctor in the selected program year.

Separate record types

Research & Ownership

Research Payments (direct recipient): not present in the loaded data

Associated Research Funding (for example, named PI): not present in the loaded data

Ownership / Investment: not present in the loaded data

These categories are never added into the General Payments headline. Associated research funding must not be described as money the doctor personally received unless the source record supports that conclusion.

Analysis 1 · Payment-linked products

Products named in Open Payments records

No payment-linked product analysis is available because no matching General Payment records were found for the selected year.

Public prescribing for products named in payments

There is no explicit payment-product set available for a Part D comparison.

The presence of the same drug in both datasets does not show that a payment caused or influenced a prescription.

Analysis 2 · Same-company prescribing overlap

Drugs reported in other payments from the same company that also appear in Medicare Part D

This analysis is independent from products named on this doctor’s individual payment records. A row appears only when the exact Open Payments reporting entity paid this doctor, that same reporting entity reported the drug or biological on at least 10 loaded General Payment records involving at least 2 distinct recipient NPIs, and this doctor has the same non-generic brand in public Part D data. This does not mean the company owns or manufactures the drug.

There is no payer-company set available for this comparison.

These facts do not show that a payment was for the drug, that the company owns or manufactures the drug, or that a payment caused or influenced prescribing.

Public Medicare Part D data

Provider-and-drug rows loaded for 2024

Brand	Generic	Claims	Beneficiaries
Atorvastatin Calcium	Atorvastatin Calcium	557	168
Levothyroxine Sodium	Levothyroxine Sodium	337	94
Amlodipine Besylate	Amlodipine Besylate	261	79
Pantoprazole Sodium	Pantoprazole Sodium	259	84
Lisinopril	Lisinopril	223	62
Metformin Hcl Er	Metformin Hcl	185	58
Gabapentin	Gabapentin	177	43
Losartan Potassium	Losartan Potassium	150	48
Metoprolol Succinate	Metoprolol Succinate	147	48
Hydrochlorothiazide	Hydrochlorothiazide	145	39
Mounjaro	Tirzepatide	139	25
Potassium Chloride	Potassium Chloride	136	26
Furosemide	Furosemide	132	27
Trazodone Hcl	Trazodone Hcl	132	32
Omeprazole	Omeprazole	128	43
Montelukast Sodium	Montelukast Sodium	127	43
Albuterol Sulfate Hfa	Albuterol Sulfate	126	54
Allopurinol	Allopurinol	116	20
Prednisone	Prednisone	114	42
Valsartan	Valsartan	113	31
Rosuvastatin Calcium	Rosuvastatin Calcium	111	34
Metformin Hcl	Metformin Hcl	108	35
Sertraline Hcl	Sertraline Hcl	106	28
Tamsulosin Hcl	Tamsulosin Hcl	101	28
Trulicity	Dulaglutide	100	19
Alprazolam	Alprazolam	97	16
Lorazepam	Lorazepam	91	24
Fluoxetine Hcl	Fluoxetine Hcl	86	suppressed
Simvastatin	Simvastatin	85	26
Alendronate Sodium	Alendronate Sodium	81	25
Fluticasone Propionate	Fluticasone Propionate	70	26
Pravastatin Sodium	Pravastatin Sodium	70	21
Colestipol Hcl	Colestipol Hcl	63	suppressed
Lantus Solostar	Insulin Glargine,hum.Rec.Anlog	62	17
Hydrocodone-Acetaminophen	Hydrocodone/Acetaminophen	60	19
Metoprolol Tartrate	Metoprolol Tartrate	59	19
Duloxetine Hcl	Duloxetine Hcl	58	16
Triamterene-Hydrochlorothiazid	Triamterene/Hydrochlorothiazid	58	14
Meloxicam	Meloxicam	54	18
Tramadol Hcl	Tramadol Hcl	53	13
Atenolol	Atenolol	50	12
Carvedilol	Carvedilol	50	14
Clopidogrel	Clopidogrel Bisulfate	48	16
Glipizide Er	Glipizide	48	15
Venlafaxine Hcl Er	Venlafaxine Hcl	47	12
Losartan-Hydrochlorothiazide	Losartan/Hydrochlorothiazide	46	15
Diclofenac Sodium	Diclofenac Sodium	44	15
Januvia	Sitagliptin Phosphate	44	12
Escitalopram Oxalate	Escitalopram Oxalate	43	12
Glipizide	Glipizide	41	11
Eliquis	Apixaban	40	suppressed
Lisinopril-Hydrochlorothiazide	Lisinopril/Hydrochlorothiazide	39	11
Synthroid	Levothyroxine Sodium	38	12
Methylprednisolone	Methylprednisolone	37	33
Xarelto	Rivaroxaban	37	suppressed
Doxycycline Hyclate	Doxycycline Hyclate	36	30
Zolpidem Tartrate	Zolpidem Tartrate	36	11
Ezetimibe	Ezetimibe	35	suppressed
Esomeprazole Magnesium	Esomeprazole Magnesium	34	suppressed
Azithromycin	Azithromycin	31	28
Citalopram Hbr	Citalopram Hydrobromide	31	11
Famotidine	Famotidine	31	11
Jardiance	Empagliflozin	31	suppressed
Amitriptyline Hcl	Amitriptyline Hcl	30	suppressed
Oxycodone-Acetaminophen	Oxycodone Hcl/Acetaminophen	29	suppressed
Bupropion Xl	Bupropion Hcl	28	suppressed
Fluticasone-Salmeterol	Fluticasone Propion/Salmeterol	28	suppressed
Meclizine Hcl	Meclizine Hcl	28	11
Methocarbamol	Methocarbamol	28	16
Budesonide-Formoterol Fumarate	Budesonide/Formoterol Fumarate	27	suppressed
Valsartan-Hydrochlorothiazide	Valsartan/Hydrochlorothiazide	27	suppressed
Topiramate	Topiramate	26	suppressed
Valacyclovir	Valacyclovir Hcl	26	15
Celecoxib	Celecoxib	25	suppressed
Chlorhexidine Gluconate	Chlorhexidine Gluconate	25	suppressed
Torsemide	Torsemide	25	suppressed
Acetaminophen-Codeine	Acetaminophen With Codeine	24	suppressed
Spironolactone	Spironolactone	24	suppressed
Nyamyc	Nystatin	23	suppressed
Oxybutynin Chloride Er	Oxybutynin Chloride	23	suppressed
Diltiazem 24hr Er (Cd)	Diltiazem Hcl	22	suppressed
Pregabalin	Pregabalin	22	suppressed
Propranolol Hcl Er	Propranolol Hcl	21	suppressed
Cyclobenzaprine Hcl	Cyclobenzaprine Hcl	20	suppressed
Nitrofurantoin Mono-Macro	Nitrofurantoin Monohyd/M-Cryst	20	17
Donepezil Hcl	Donepezil Hcl	19	suppressed
Folic Acid	Folic Acid	19	suppressed
Levetiracetam	Levetiracetam	19	suppressed
Ondansetron Hcl	Ondansetron Hcl	19	11
Ibuprofen	Ibuprofen	18	11
Ketoconazole	Ketoconazole	18	12
Humalog Kwikpen U-100	Insulin Lispro	17	suppressed
Ropinirole Hcl	Ropinirole Hcl	17	suppressed
Doxazosin Mesylate	Doxazosin Mesylate	16	suppressed
Farxiga	Dapagliflozin Propanediol	16	suppressed
Isosorbide Mononitrate Er	Isosorbide Mononitrate	16	suppressed
Risperidone	Risperidone	16	suppressed
Trelegy Ellipta	Fluticasone/Umeclidin/Vilanter	16	suppressed
Amoxicillin-Clavulanate Potass	Amoxicillin/Potassium Clav	15	13
Oxycodone Hcl	Oxycodone Hcl	15	suppressed
Paroxetine Hcl	Paroxetine Hcl	15	suppressed
Ramipril	Ramipril	15	suppressed
Azelastine Hcl	Azelastine Hcl	14	suppressed
Benazepril Hcl	Benazepril Hcl	14	suppressed
Dicyclomine Hcl	Dicyclomine Hcl	14	suppressed
Fiasp Flextouch	Insulin Aspart (Niacinamide)	14	suppressed
Klor-Con M20	Potassium Chloride	14	suppressed
Anoro Ellipta	Umeclidinium Brm/Vilanterol Tr	13	suppressed
Bisoprolol-Hydrochlorothiazide	Bisoprolol/Hydrochlorothiazide	13	suppressed
Buspirone Hcl	Buspirone Hcl	13	suppressed
Finasteride	Finasteride	13	suppressed
Irbesartan	Irbesartan	13	suppressed
Levofloxacin	Levofloxacin	13	12
Nystatin	Nystatin	13	suppressed
Promethazine Hcl	Promethazine Hcl	13	suppressed
Triamcinolone Acetonide	Triamcinolone Acetonide	13	suppressed
Ultra-Fine Short Pen Needle	Pen Needle, Diabetic	13	suppressed
Estradiol	Estradiol	12	suppressed
Paliperidone Er	Paliperidone	12	suppressed
Qvar Redihaler	Beclomethasone Dipropionate	12	suppressed
Rocklatan	Netarsudil Mesylat/Latanoprost	12	suppressed
Lovastatin	Lovastatin	11	suppressed
Primidone	Primidone	11	suppressed
Wegovy	Semaglutide	11	suppressed

Timeline

Payment and prescribing data by year

Open Payments and Medicare Part D may refer to different years. They are shown separately rather than aligned as if they describe the same period.

Year	General Payments	Main payer	Explicit products	Company overlaps	Part D coverage
2025	—	—	—	—	—
2024	—	—	—	—	Complete

Questions to ask

Questions you could discuss with your doctor

Are there reasonable alternatives I should understand when we discuss treatment options?
How should I interpret the industry-payment records shown here in the context of my care?

These are general questions generated from reviewed templates. They are not personalized medical advice.

Sources and limitations

How to read this page

Payment and Medicare prescribing data can cover different years; every comparison shows both years explicitly.
Part D does not represent a doctor’s entire practice; it excludes many patients and is subject to CMS public-release thresholds.
Company–drug relationships must have an auditable source, a precise relationship type, and a valid evidence period. Unresolved mappings are not published.
Generic drug claims are not attributed to a specific manufacturer without manufacturer-level evidence.
When a source extract is incomplete, missing rows are never treated as proof of no payments or no prescriptions.

Loaded source releases

Dataset	Year	Publication	Source
CMS Open Payments — General Payments	2025	2026-06-30	Original source
Medicare Part D Prescribers by Provider and Drug	2024	2026-05-06	Original source
NPPES Data Dissemination V2	current / reference data	2026-08-10	Original source

Methodology version: 2.1

Editorial template version: 2.4

Product contract version: 2.0

Schema version: 0.7.0

Page data build: 2026-08-12T23:34:59.370714+00:00

Publication policy: eligible for indexing after public-launch controls are enabled

Full methodology · Questions & answers · Report a possible error